Cargando…
In Vivo CRISPR/Cas9 Gene Editing Corrects Retinal Dystrophy in the S334ter-3 Rat Model of Autosomal Dominant Retinitis Pigmentosa
Reliable genome editing via Clustered Regularly Interspaced Short Palindromic Repeat (CRISPR)/Cas9 may provide a means to correct inherited diseases in patients. As proof of principle, we show that CRISPR/Cas9 can be used in vivo to selectively ablate the rhodopsin gene carrying the dominant S334ter...
Autores principales: | Bakondi, Benjamin, Lv, Wenjian, Lu, Bin, Jones, Melissa K, Tsai, Yuchun, Kim, Kevin J, Levy, Rachelle, Akhtar, Aslam Abbasi, Breunig, Joshua J, Svendsen, Clive N, Wang, Shaomei |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4786918/ https://www.ncbi.nlm.nih.gov/pubmed/26666451 http://dx.doi.org/10.1038/mt.2015.220 |
Ejemplares similares
-
Inhibition of Matrix Metalloproteinase 9 Enhances Rod Survival in the S334ter-line3 Retinitis Pigmentosa Model
por: Shin, Jung-A, et al.
Publicado: (2016) -
ER Stress in Retinal Degeneration in S334ter Rho Rats
por: Shinde, Vishal M., et al.
Publicado: (2012) -
AAV-CRISPR/Cas9 Gene Editing Preserves Long-Term Vision in the P23H Rat Model of Autosomal Dominant Retinitis Pigmentosa
por: Shahin, Saba, et al.
Publicado: (2022) -
Mass spectrometric analyses of phospholipids in the S334ter-3 rat model of retinal degeneration
por: Chen, Caroline Y., et al.
Publicado: (2014) -
Gene therapy in animal models of autosomal dominant retinitis pigmentosa
por: Rossmiller, Brian, et al.
Publicado: (2012)